Microbio Co., Ltd. (TPEX:4128)

Microbio Statistics

Total Valuation

Microbio has a market cap or net worth of TWD 12.73 billion. The enterprise value is 12.18 billion.

Market Cap	12.73B
Enterprise Value	12.18B

Important Dates

The last earnings date was Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Microbio has 588.17 million shares outstanding.

Current Share Class	588.17M
Shares Outstanding	588.17M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.08%
Owned by Institutions (%)	6.49%
Float	428.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.85
PB Ratio	1.22
P/TBV Ratio	1.44
P/FCF Ratio	112.87
P/OCF Ratio	79.00
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-11.80
EV / Sales	6.55
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	107.96

Financial Position

The company has a current ratio of 5.22, with a Debt / Equity ratio of 0.06.

Current Ratio	5.22
Quick Ratio	4.76
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	5.72
Interest Coverage	-36.33

Financial Efficiency

Return on equity (ROE) is -10.35% and return on invested capital (ROIC) is -2.09%.

Return on Equity (ROE)	-10.35%
Return on Assets (ROA)	-1.87%
Return on Invested Capital (ROIC)	-2.09%
Return on Capital Employed (ROCE)	-3.40%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.14
Inventory Turnover	5.64

Taxes

Income Tax	-183,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.20% in the last 52 weeks. The beta is 0.55, so Microbio's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	-47.20%
50-Day Moving Average	21.60
200-Day Moving Average	24.41
Relative Strength Index (RSI)	54.69
Average Volume (20 Days)	2,456,416

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Microbio had revenue of TWD 1.86 billion and -1.03 billion in losses. Loss per share was -1.76.

Revenue	1.86B
Gross Profit	727.79M
Operating Income	-403.23M
Pretax Income	-1.18B
Net Income	-1.03B
EBITDA	-304.29M
EBIT	-403.23M
Loss Per Share	-1.76

Balance Sheet

The company has 2.58 billion in cash and 645.23 million in debt, giving a net cash position of 1.93 billion or 3.29 per share.

Cash & Cash Equivalents	2.58B
Total Debt	645.23M
Net Cash	1.93B
Net Cash Per Share	3.29
Equity (Book Value)	10.40B
Book Value Per Share	15.33
Working Capital	2.36B

Cash Flow

In the last 12 months, operating cash flow was 161.19 million and capital expenditures -48.37 million, giving a free cash flow of 112.82 million.

Operating Cash Flow	161.19M
Capital Expenditures	-48.37M
Free Cash Flow	112.82M
FCF Per Share	0.19

Margins

Gross margin is 39.16%, with operating and profit margins of -21.70% and -55.53%.

Gross Margin	39.16%
Operating Margin	-21.70%
Pretax Margin	-63.77%
Profit Margin	-55.53%
EBITDA Margin	-16.37%
EBIT Margin	-21.70%
FCF Margin	6.07%

Dividends & Yields

Microbio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-8.10%
FCF Yield	0.89%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 29, 2024. It was a forward split with a ratio of 1.049999998.

Last Split Date	Aug 29, 2024
Split Type	Forward
Split Ratio	1.049999998

Scores

Microbio has an Altman Z-Score of 5.23 and a Piotroski F-Score of 4.

Altman Z-Score	5.23
Piotroski F-Score	4